Skip to Content

Menostar FDA Approval History

FDA Approved: Yes (First approved June 8, 2004)
Brand name: Menostar
Generic name: estradiol transdermal system
Company: Berlex
Treatment for: Prevention of Osteoporosis

Menostar (estradiol transdermal system) is an estrogen patch for the prevention of postmenopausal osteoporosis.

Development Timeline for Menostar

DateArticle
Jun  8, 2004Approval Menostar Berlex - Treatment for Osteoporosis Prevention

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.